Clemens Bauer Hoss

Sponsor: NIH

Auditory hallucinations are one of the five cardinal symptoms of schizophrenia and one of the most distressing. Almost a third of patients experiencing auditory hallucinations are not responsive to gold-standard pharmacological and psychotherapeutic treatment. We have pioneered a new non-invasive treatment candidate, computational neuroscience-based approach, also known as network-based real-time functional Magnetic Resonance Imaging (fMRI) Neurofeedback that is a well-tolerated and effective approach for reducing the severity and frequency of auditory hallucinations. However, because this technique currently requires fMRI to deliver neurofeedback, which unfortunately is an expensive procedure involving a complex setup and participant burden, this NIH award will help develop novel, non-invasive, personalized, and scalable treatments that will improve outcomes and reduce relapse rates among schizophrenia patients with treatment resistant auditory hallucinations.